Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels

Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels

As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two steps: firs...

Full description

Bibliographic Details
Main Authors:	Bottomley, C, Otiende, M, Uyoga, S, Agweyu, A, Warimwe, GM, Scott, J
Format:	Journal article
Language:	English
Published:	Springer Nature 2021

Similar Items

Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
by: C. Bottomley, et al.
Published: (2021-10-01)

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
by: Uyoga, S, et al.
Published: (2021)

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
by: Nyagwange, J, et al.
Published: (2021)

Seroprevalence of antibodies to SARS-CoV-2 among health care workers in Kenya
by: Etyang, AO, et al.
Published: (2021)

Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?
by: Lippi Giuseppe, et al.
Published: (2023-03-01)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
by: Silvina Raiden, et al.
Published: (2022-02-01)

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
by: Adetifa, IMO, et al.
Published: (2021)

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
by: Kaori Sano, et al.
Published: (2022-09-01)

Effect of the Previous History of the SARS-CoV-2 Infections on Antibody Levels among Sputnik V Vaccinated Healthcare Workers
by: Atieh Yaghoubi, et al.
Published: (2023-03-01)

Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2
by: Theocharis G. Konstantinidis, et al.
Published: (2021-06-01)

Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
by: Jing Wang, et al.
Published: (2023-04-01)

Fast and real-time electrical transistor assay for quantifying SARS-CoV-2 neutralizing antibodies
by: Francesco Decataldo, et al.
Published: (2022-01-01)

Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants
by: F. Javier Ibarrondo, et al.
Published: (2021-12-01)

The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization
by: Lorraine Sazgary, et al.
Published: (2021-06-01)

Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
by: Nyagwange, J, et al.
Published: (2022)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
by: Yong Xia, et al.
Published: (2020-07-01)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
by: Huibin Lv, et al.
Published: (2020-06-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
by: Etyang, AO, et al.
Published: (2022)

Evaluation of specific IgG antibody in subjects who had been previously infected with SARS-CoV-2
by: Soodabeh Rostami, et al.
Published: (2023-01-01)

Longer Intervals before Vaccination Increase Spike Antibody Titers in Individuals Previously Infected with SARS-CoV-2
by: Xiuqiong Bi, et al.
Published: (2022-04-01)

ANTIBODY RESPONSE AFTER SARS-CoV-2 mRNA VACCINE IN NAÏVE AND PREVIOUSLY INFECTED HEALTHCARE WORKERS
by: Adina Huțanu, et al.
Published: (2021-12-01)

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
by: Ifedayo M. O. Adetifa, et al.
Published: (2021-06-01)

Delaying surgery for patients with a previous SARS-CoV-2 infection
by: Glasbey, JC, et al.
Published: (2020)

A Neuropsychiatric Assessment of Children with Previous SARS-CoV-2 Infection
by: Veronica Scarselli, et al.
Published: (2023-06-01)

Delayed Kawasaki disease in an adult previously infected with SARS-CoV-2
by: Sheila Wang, MD, PhD, et al.
Published: (2022-05-01)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
by: Ren Yang, et al.
Published: (2020-08-01)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
by: Qingqing Lin, et al.
Published: (2020-10-01)

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
by: Jing Zou, et al.
Published: (2022-02-01)

SARS-CoV-2 and Anti-Cardiolipin Antibodies
by: Mazen Jizzini, et al.
Published: (2020-12-01)

Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults
by: Amy C. Thomas, et al.
Published: (2023-03-01)

Outliers Matter—Correlation between S1 IgG SARS-CoV-2 Antibodies and Neutralizing SARS-CoV-2 Antibodies
by: Berthold Hocher, et al.
Published: (2022-10-01)

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
by: Roper, KJ, et al.
Published: (2023)

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
by: Kelly J. Roper, et al.
Published: (2023-09-01)

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
by: Ruofan Li, et al.
Published: (2022-08-01)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021-01-01)

Serious dengue in a woman with previous infection due to SARS-CoV-2
by: Alejandro David Fernández Gómez, et al.
Published: (2023-06-01)

Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees
by: N. Kojima, et al.
Published: (2022-05-01)

Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID
by: Benjamin A. Krishna, et al.
Published: (2022-07-01)

Vaccine against SARS-CoV-2 in previously infected health care workers
by: Saverio Giuseppe Parisi
Published: (2021-09-01)